SCHEMBL22076698

SCHEMBL22076698

CC(C)Oc1c(NC(=O)c2ccc(NC(=O)C(CC(N)=O)NC(=O)c3ccc(NC(=O)c4ccc(NC(N)=O)cc4)cc3)cc2)ccc(C(=O)Nc2ccc(C(=O)O)cc2)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 1/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ PLG P00747 1/20 0.35
▸ PLAU P00749 1/20 0.35
▸ EP300 Q09472 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ F3 P13726 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HDAC1 Q13547 3/20 0.34
▸ HDAC3 O15379 2/20 0.34
▸ HDAC2 Q92769 2/20 0.34
▸ NCOR2 Q9Y618 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22076696 1.00 MMP2 (0.38) MMP2MEN1KMT2ARXFP1GLA
SCHEMBL20764481 0.95 MEN1 (0.44) MMP2MEN1KMT2ARXFP1PLG
SCHEMBL20764482 0.95 MEN1 (0.44) MMP2MEN1KMT2ARXFP1PLG
SCHEMBL20764473 0.94 MEN1 (0.37) MMP2MEN1KMT2ARXFP1PLG
SCHEMBL20764600 0.94 CACNA1B (0.37) MMP2MEN1KMT2ARXFP1PLG
SCHEMBL20764599 0.94 CACNA1B (0.37) MMP2MEN1KMT2ARXFP1PLG
SCHEMBL20764477 0.94 MEN1 (0.37) MMP2MEN1KMT2ARXFP1PLG
SCHEMBL20764475 0.93 MITF (0.43) MMP2NPC1HDAC1HDAC3HDAC2
SCHEMBL20764478 0.93 MITF (0.43) MMP2NPC1HDAC1HDAC3HDAC2
SCHEMBL20764715 0.93 EP300 (0.40) MMP2MEN1KMT2ARXFP1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034648-B2 Cystobactamide derivatives HELMHOLTZ-ZENTRUM FÜR (DE) 2021-06-15 — — US disclosed
US-20200190020-A1 NOVEL CYSTOBACTAMIDE DERIVATIVES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-06-18 — — US disclosed
CN-110997627-A Novel cystobacter amide derivatives 亥姆霍兹感染研究中心有限公司 2020-04-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034648-B2 Cystobactamide derivatives CTH, CBS, SLC7A11 MMP2 1631/4885MEN1 2023/4885KMT2A 2115/4885
US-20200190020-A1 NOVEL CYSTOBACTAMIDE DERIVATIVES CTH, CBS, SLC7A11 MMP2 1862/4885MEN1 2097/4885KMT2A 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback